Loading…
Wednesday April 30, 2025 11:45am - 12:30pm PDT
Integrating R&D and commercial perspectives during due diligence ensures strategic alignment, enhances market readiness, and maximizes long-term value.

  • Highlight the advantages of integrating R&D and commercial insights early in the due diligence process.
  • Ensure strategic alignment with market needs, patient demographics, and development pathways to maximize long-term value.
  • Define clear timelines and expectations for clinical program development and its connection to commercial success.
Moderators
avatar for Brian Bronk

Brian Bronk

Head of Business Development, MS/Neurology, Rare & Rare Blood & Innovative Technologies, Sanofi
Speakers
avatar for Niels Emmerich

Niels Emmerich

Vice President, Global Head Search & Evaluation, Abbvie
avatar for Wyatt McDonnell

Wyatt McDonnell

CEO & Founding Scientist, Infinimmune
avatar for Bob Draper

Bob Draper

Vice President, Innovation and Strategics Insights Hub Leader, Eli Lilly and Company
Wednesday April 30, 2025 11:45am - 12:30pm PDT
Town & Country Ballroom A Town & Country Resort, 500 Hotel Cir N, San Diego, CA 92108, USA

Log in to save this to your schedule, view media, leave feedback and see who's attending!

Share Modal

Share this link via

Or copy link